Sponsor:
AstraZeneca
Code:
NCT05583227
Conditions
Eosinophilic Esophagitis
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
Tezepelumab
Tezepelumab
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations